Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
WASHINGTON, D.C., March 13, 2018 -- In a new story for Inside Science News Service, Joel Shurkin offers an intimate look at why Alzheimer's research is failing to help patients, including his own wife. Inside Science is an editorially-independent nonprofit journalism venture operated by the American Institute of Physics.
Researchers have long believed that Alzheimer's disease symptoms are caused by protein deposits called "amyloid plaques." But the amyloid model may be wrong, writes Shurkin, and that could explain why so many new drugs have failed in clinical trials. Shurkin's wife was a patient in a now-canceled trial, and her story offers a poignant glimpse of the human cost of such failures.
Shurkin explains the science that led to the amyloid model, as well as the creeping doubts now rising amongst Alzheimer's researchers. He goes on to describe potential new directions for future research -- research that will be too late for his wife, but perhaps life-saving for others down the road.
####
ABOUT INSIDE SCIENCE
Inside Science is an editorially-independent nonprofit science news service run out of the American Institute of Physics and supported by a coalition of underwriters. It produces original breaking news stories, features, essays, illustrations, documentaries, animations and news videos, all of which are procurable for syndication by news organizations or available on our web site. https://www.insidescience.org
ABOUT AIP
The American Institute of Physics is an organization of physical science societies, representing scientists, engineers, educators, and students. AIP delivers valuable services and expertise in education and student programs, science communications, government relations, career
AIP Media American Institute of Physics 301-209-3090 [email protected]
